Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis

Objectives. Adalimumab, etanercept and infliximab are effective TNF inhibitors (TNFis) in the treatment of RA, but no randomized clinical trials have compared the three agents. Prior observational data are not consistent. We compared their effectiveness over 1 year in a prospective cohort. Methods....

詳細記述

保存先:
書誌詳細
主要な著者: Canhão, Helena, Rodrigues, Ana Maria, Mourão, Ana Filipa, Martins, Fernando, Santos, Maria José, Canas-Silva, José, Polido-Pereira, Joaquim, Pereira Silva, José Alberto, Costa, José António, Araújo, Domingos, Silva, Cândida, Santos, Helena, Duarte, Cátia, da Silva, José Antonio Pereira, Pimentel-Santos, Fernando M., Branco, Jaime Cunha, Karlson, Elizabeth W., Fonseca, João Eurico, Solomon, Daniel H.
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2012
主題:
Clinical Science
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3475979/
https://ncbi.nlm.nih.gov/pubmed/22843791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kes184
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料